JPMORGAN CHASE & CO - HEALTH CATALYST INC ownership

HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 88 filers reported holding HEALTH CATALYST INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of HEALTH CATALYST INC
ValueSharesWeighting
Q3 2023$20,032,147
-23.9%
1,979,461
-6.0%
0.00%
-33.3%
Q2 2023$26,314,052
+21.1%
2,105,124
+13.0%
0.00%0.0%
Q1 2023$21,735,000
+86245.9%
1,862,515
-21.3%
0.00%0.0%
Q4 2022$25,172
-99.8%
2,367,886
+65.7%
0.00%
+50.0%
Q3 2022$13,866,000
+233.8%
1,429,446
+398.5%
0.00%
+100.0%
Q2 2022$4,154,000
+26.5%
286,727
+128.2%
0.00%
Q1 2022$3,283,000
+2.6%
125,655
+55.5%
0.00%
Q4 2021$3,201,000
+56.5%
80,812
+97.6%
0.00%
Q3 2021$2,045,000
+40.5%
40,893
+55.9%
0.00%
Q2 2021$1,455,000
-7.4%
26,226
-22.0%
0.00%
Q1 2021$1,572,000
-31.4%
33,625
-36.2%
0.00%
Q4 2020$2,292,000
+9.5%
52,664
-7.5%
0.00%
Q3 2020$2,093,000
+170.8%
56,929
+115.1%
0.00%
Q2 2020$773,000
-86.2%
26,466
-87.7%
0.00%
-100.0%
Q1 2020$5,611,000
+941.0%
214,570
+1280.9%
0.00%
Q4 2019$539,000
+541.7%
15,538
+483.7%
0.00%
Q3 2019$84,0002,6620.00%
Other shareholders
HEALTH CATALYST INC shareholders Q3 2019
NameSharesValueWeighting ↓
Norwest Venture Partners XI, LP 876,045$32,063,000100.00%
Norwest Venture Partners XII, LP 876,045$32,063,00069.68%
Nepsis Inc. 197,178$7,217,0003.46%
Karani Asset Management LLC 133,968$4,903,0003.29%
ADAMS STREET PARTNERS LLC 201,548$6,639,0001.75%
HHR Asset Management, LLC 412,423$15,095,0001.50%
Mesirow Financial Investment Management, Inc. 9,510$348,0001.49%
ASHFORD CAPITAL MANAGEMENT INC 342,500$12,536,0001.49%
Roubaix Capital, LLC 31,889$1,167,0001.38%
Monarch Partners Asset Management LLC 154,847$5,667,0001.28%
View complete list of HEALTH CATALYST INC shareholders